Key statistics
As of last trade Vistin Pharma ASA (VP4:STU) traded at 1.97, -12.67% below its 52-week high of 2.25, set on Jun 03, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 1.93 |
|---|---|
| High | 1.97 |
| Low | 1.93 |
| Bid | 1.97 |
| Offer | 2.02 |
| Previous close | 1.93 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 44.34m |
| Free float | 18.21m |
| P/E (TTM) | 13.29 |
| Market cap | 993.32m NOK |
| EPS (TTM) | 1.69 NOK |
| Annual div (ADY) | 0.089 EUR |
|---|---|
| Annual div yield (ADY) | 4.53% |
| Div ex-date | Jun 04 2025 |
| Div pay-date | Jun 12 2025 |
| Next div ex-date | May 22 2026 |
| Next div pay-date | May 29 2026 |
Data delayed at least 15 minutes, as of Feb 27 2026.
More ▼
Announcements
- Vistin Pharma ASA: Mandatory notification of trade
- Vistin Pharma ASA (VISTN): Key information relating to the proposed cash dividend
- Vistin Pharma ASA: Fourth quarter and preliminary 2025 financial results
- Vistin Pharma ASA (VISTN): Invitation to Q4 2025 conference call
- Vistin Pharma ASA: Third quarter and YTD 2025 financial results
- Vistin Pharma ASA: Invitation to Q3 2025 conference call
- Vistin Pharma ASA: Second quarter and YTD 2025 financial results
- Vistin Pharma ASA: Invitation to Q2 2025 conference call
- Ex dividend NOK 1.25 today
- Vistin Pharma ASA: Minutes from the annual general meeting 2025
More ▼
